USA Made Advantage Position INRAD's in-house US manufacturing as a differentiator to potential hospital and clinic buyers seeking domestic production for quality control, regulatory compliance, and shorter supply chains.

Clinical Collaboration Highlight INRAD's collaboration with leading physicians in designing core biopsy needles, breast biopsy markers, and interventional products to open doors with medical centers prioritizing surgeon and radiologist input in product selection.

Midmarket Focus With a revenue range of 1–10 million and a lean team, target mid-tier hospitals, outpatient centers, and regional radiology groups that may be under-served by larger incumbents, offering personalized service and rapid support.

Precision Portfolio Emphasize the specialty equipment catalog (biopsy needles, markers, and interventional devices) to cross-sell complementary tools, accessories, and maintenance services to existing radiology departments.

Growth Partnerships Leverage the current tech stack and online presence to deploy targeted digital outreach, case studies, and clinical data that demonstrate outcomes, encouraging procurement teams to pilot INRAD products in select facilities.